These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7659195)

  • 1. Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats.
    Rodríguez de Fonseca FR; Villanúa MA; Muñoz RM; San-Martin-Clark O; Navarro M
    Neuroendocrinology; 1995 Jun; 61(6):714-21. PubMed ID: 7659195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide.
    Solinas M; Tanda G; Wertheim CE; Goldberg SR
    Psychopharmacology (Berl); 2010 Apr; 209(2):191-202. PubMed ID: 20179908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats.
    Rodríguez de Fonseca F; Martín Calderón JL; Mechoulam R; Navarro M
    Neuroreport; 1994 Mar; 5(7):761-5. PubMed ID: 7912554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.
    García-Gil L; De Miguel R; Muñoz RM; Cebeira M; Villanua MA; Ramos JA; Fernández-Ruiz JJ
    Neurotoxicol Teratol; 1997; 19(6):477-87. PubMed ID: 9392783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas.
    Rodríguez De Fonseca F; Fernández-Ruiz JJ; Murphy LL; Cebeira M; Steger RW; Bartke A; Ramos JA
    Pharmacol Biochem Behav; 1992 Jun; 42(2):269-75. PubMed ID: 1321451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.
    Bonnin A; Ramos JA; Rodríguez de Fonseca F; Cebeira M; Fernández-Ruiz JJ
    Neuroendocrinology; 1993 Sep; 58(3):280-6. PubMed ID: 7902959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.
    Daigle TL; Wetsel WC; Caron MG
    Eur J Neurosci; 2011 Nov; 34(9):1378-89. PubMed ID: 22034973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
    Darmani NA; Crim JL
    Pharmacol Biochem Behav; 2005 Jan; 80(1):35-44. PubMed ID: 15652378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats.
    Moreno M; Lopez-Moreno JA; Rodríguez de Fonseca F; Navarro M
    Behav Pharmacol; 2005 Sep; 16(5-6):441-6. PubMed ID: 16148449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring.
    del Arco I; Muñoz R; Rodríguez De Fonseca F; Escudero L; Martín-Calderón JL; Navarro M; Villanúa MA
    Neuroimmunomodulation; 2000; 7(1):16-26. PubMed ID: 10601815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.
    Navarro M; Fernández-Ruiz JJ; de Miguel R; Hernández ML; Cebeira M; Ramos JA
    Behav Brain Res; 1993 Oct; 57(1):37-46. PubMed ID: 8292253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens.
    Bonnin A; Fernández-Ruiz JJ; Martín M; Rodríguez de Fonseca F; Hernández ML; Ramos JA
    J Neural Transm Gen Sect; 1993; 92(2-3):81-95. PubMed ID: 8103663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210.
    Serrano A; Vadas E; Ferrer B; Bilbao A; Granado N; Suárez J; Pavon FJ; Moratalla R; Rodríguez de Fonseca F
    Psychopharmacology (Berl); 2021 Feb; 238(2):551-557. PubMed ID: 33410990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.
    Martín-Calderón JL; Muñoz RM; Villanúa MA; del Arco I; Moreno JL; de Fonseca FR; Navarro M
    Eur J Pharmacol; 1998 Feb; 344(1):77-86. PubMed ID: 9580419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats.
    Moreno M; Trigo JM; Escuredo L; Rodríguez de Fonseca F; Navarro M
    Pharmacol Biochem Behav; 2003 Jun; 75(3):565-75. PubMed ID: 12895674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.